Global Dermatology OTC Medications Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 116

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

According to our (Global Info Research) latest study, the global Dermatology OTC Medications market size was valued at USD 13150 million in 2022 and is forecast to a readjusted size of USD 16350 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.

This report is a detailed and comprehensive analysis for global Dermatology OTC Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Dermatology OTC Medications market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/Unit), 2018-2029
Global Dermatology OTC Medications market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dermatology OTC Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dermatology OTC Medications market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, GSK, Teva, Johnson & Johnson and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Dermatology OTC Medications market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    External Use
    Oral

Market segment by Application
    Hospital
    Drug Store
    Other

Major players covered
    Bayer
    GSK
    Teva
    Johnson & Johnson
    Novartis
    Mylan
    Sun Pharmaceutical
    Aurobindo
    Galderma
    CR SANJIU
    Dr. Reddy's
    Lupin
    Bausch Health
    Cipla
    Qilu Pharmaceutical
    Almirall
    Lingrui

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology OTC Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dermatology OTC Medications, with price, sales, revenue and global market share of Dermatology OTC Medications from 2018 to 2023.
Chapter 3, the Dermatology OTC Medications competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology OTC Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Dermatology OTC Medications market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dermatology OTC Medications.
Chapter 14 and 15, to describe Dermatology OTC Medications sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Dermatology OTC Medications
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Dermatology OTC Medications Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 External Use
        1.3.3 Oral
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Dermatology OTC Medications Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Drug Store
        1.4.4 Other
    1.5 Global Dermatology OTC Medications Market Size & Forecast
        1.5.1 Global Dermatology OTC Medications Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Dermatology OTC Medications Sales Quantity (2018-2029)
        1.5.3 Global Dermatology OTC Medications Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Dermatology OTC Medications Product and Services
        2.1.4 Bayer Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bayer Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Dermatology OTC Medications Product and Services
        2.2.4 GSK Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GSK Recent Developments/Updates
    2.3 Teva
        2.3.1 Teva Details
        2.3.2 Teva Major Business
        2.3.3 Teva Dermatology OTC Medications Product and Services
        2.3.4 Teva Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Teva Recent Developments/Updates
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Dermatology OTC Medications Product and Services
        2.4.4 Johnson & Johnson Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Johnson & Johnson Recent Developments/Updates
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Dermatology OTC Medications Product and Services
        2.5.4 Novartis Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Novartis Recent Developments/Updates
    2.6 Mylan
        2.6.1 Mylan Details
        2.6.2 Mylan Major Business
        2.6.3 Mylan Dermatology OTC Medications Product and Services
        2.6.4 Mylan Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Mylan Recent Developments/Updates
    2.7 Sun Pharmaceutical
        2.7.1 Sun Pharmaceutical Details
        2.7.2 Sun Pharmaceutical Major Business
        2.7.3 Sun Pharmaceutical Dermatology OTC Medications Product and Services
        2.7.4 Sun Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Sun Pharmaceutical Recent Developments/Updates
    2.8 Aurobindo
        2.8.1 Aurobindo Details
        2.8.2 Aurobindo Major Business
        2.8.3 Aurobindo Dermatology OTC Medications Product and Services
        2.8.4 Aurobindo Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Aurobindo Recent Developments/Updates
    2.9 Galderma
        2.9.1 Galderma Details
        2.9.2 Galderma Major Business
        2.9.3 Galderma Dermatology OTC Medications Product and Services
        2.9.4 Galderma Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Galderma Recent Developments/Updates
    2.10 CR SANJIU
        2.10.1 CR SANJIU Details
        2.10.2 CR SANJIU Major Business
        2.10.3 CR SANJIU Dermatology OTC Medications Product and Services
        2.10.4 CR SANJIU Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 CR SANJIU Recent Developments/Updates
    2.11 Dr. Reddy's
        2.11.1 Dr. Reddy's Details
        2.11.2 Dr. Reddy's Major Business
        2.11.3 Dr. Reddy's Dermatology OTC Medications Product and Services
        2.11.4 Dr. Reddy's Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Dr. Reddy's Recent Developments/Updates
    2.12 Lupin
        2.12.1 Lupin Details
        2.12.2 Lupin Major Business
        2.12.3 Lupin Dermatology OTC Medications Product and Services
        2.12.4 Lupin Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Lupin Recent Developments/Updates
    2.13 Bausch Health
        2.13.1 Bausch Health Details
        2.13.2 Bausch Health Major Business
        2.13.3 Bausch Health Dermatology OTC Medications Product and Services
        2.13.4 Bausch Health Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Bausch Health Recent Developments/Updates
    2.14 Cipla
        2.14.1 Cipla Details
        2.14.2 Cipla Major Business
        2.14.3 Cipla Dermatology OTC Medications Product and Services
        2.14.4 Cipla Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Cipla Recent Developments/Updates
    2.15 Qilu Pharmaceutical
        2.15.1 Qilu Pharmaceutical Details
        2.15.2 Qilu Pharmaceutical Major Business
        2.15.3 Qilu Pharmaceutical Dermatology OTC Medications Product and Services
        2.15.4 Qilu Pharmaceutical Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Qilu Pharmaceutical Recent Developments/Updates
    2.16 Almirall
        2.16.1 Almirall Details
        2.16.2 Almirall Major Business
        2.16.3 Almirall Dermatology OTC Medications Product and Services
        2.16.4 Almirall Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Almirall Recent Developments/Updates
    2.17 Lingrui
        2.17.1 Lingrui Details
        2.17.2 Lingrui Major Business
        2.17.3 Lingrui Dermatology OTC Medications Product and Services
        2.17.4 Lingrui Dermatology OTC Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Lingrui Recent Developments/Updates

3 Competitive Environment: Dermatology OTC Medications by Manufacturer
    3.1 Global Dermatology OTC Medications Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Dermatology OTC Medications Revenue by Manufacturer (2018-2023)
    3.3 Global Dermatology OTC Medications Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Dermatology OTC Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Dermatology OTC Medications Manufacturer Market Share in 2022
        3.4.2 Top 6 Dermatology OTC Medications Manufacturer Market Share in 2022
    3.5 Dermatology OTC Medications Market: Overall Company Footprint Analysis
        3.5.1 Dermatology OTC Medications Market: Region Footprint
        3.5.2 Dermatology OTC Medications Market: Company Product Type Footprint
        3.5.3 Dermatology OTC Medications Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Dermatology OTC Medications Market Size by Region
        4.1.1 Global Dermatology OTC Medications Sales Quantity by Region (2018-2029)
        4.1.2 Global Dermatology OTC Medications Consumption Value by Region (2018-2029)
        4.1.3 Global Dermatology OTC Medications Average Price by Region (2018-2029)
    4.2 North America Dermatology OTC Medications Consumption Value (2018-2029)
    4.3 Europe Dermatology OTC Medications Consumption Value (2018-2029)
    4.4 Asia-Pacific Dermatology OTC Medications Consumption Value (2018-2029)
    4.5 South America Dermatology OTC Medications Consumption Value (2018-2029)
    4.6 Middle East and Africa Dermatology OTC Medications Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    5.2 Global Dermatology OTC Medications Consumption Value by Type (2018-2029)
    5.3 Global Dermatology OTC Medications Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    6.2 Global Dermatology OTC Medications Consumption Value by Application (2018-2029)
    6.3 Global Dermatology OTC Medications Average Price by Application (2018-2029)

7 North America
    7.1 North America Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    7.2 North America Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    7.3 North America Dermatology OTC Medications Market Size by Country
        7.3.1 North America Dermatology OTC Medications Sales Quantity by Country (2018-2029)
        7.3.2 North America Dermatology OTC Medications Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    8.2 Europe Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    8.3 Europe Dermatology OTC Medications Market Size by Country
        8.3.1 Europe Dermatology OTC Medications Sales Quantity by Country (2018-2029)
        8.3.2 Europe Dermatology OTC Medications Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Dermatology OTC Medications Market Size by Region
        9.3.1 Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    10.2 South America Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    10.3 South America Dermatology OTC Medications Market Size by Country
        10.3.1 South America Dermatology OTC Medications Sales Quantity by Country (2018-2029)
        10.3.2 South America Dermatology OTC Medications Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Dermatology OTC Medications Market Size by Country
        11.3.1 Middle East & Africa Dermatology OTC Medications Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Dermatology OTC Medications Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Dermatology OTC Medications Market Drivers
    12.2 Dermatology OTC Medications Market Restraints
    12.3 Dermatology OTC Medications Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Dermatology OTC Medications and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Dermatology OTC Medications
    13.3 Dermatology OTC Medications Production Process
    13.4 Dermatology OTC Medications Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Dermatology OTC Medications Typical Distributors
    14.3 Dermatology OTC Medications Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Dermatology OTC Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Dermatology OTC Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Bayer Basic Information, Manufacturing Base and Competitors
    Table 4. Bayer Major Business
    Table 5. Bayer Dermatology OTC Medications Product and Services
    Table 6. Bayer Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Bayer Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK Dermatology OTC Medications Product and Services
    Table 11. GSK Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GSK Recent Developments/Updates
    Table 13. Teva Basic Information, Manufacturing Base and Competitors
    Table 14. Teva Major Business
    Table 15. Teva Dermatology OTC Medications Product and Services
    Table 16. Teva Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Teva Recent Developments/Updates
    Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 19. Johnson & Johnson Major Business
    Table 20. Johnson & Johnson Dermatology OTC Medications Product and Services
    Table 21. Johnson & Johnson Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Johnson & Johnson Recent Developments/Updates
    Table 23. Novartis Basic Information, Manufacturing Base and Competitors
    Table 24. Novartis Major Business
    Table 25. Novartis Dermatology OTC Medications Product and Services
    Table 26. Novartis Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Novartis Recent Developments/Updates
    Table 28. Mylan Basic Information, Manufacturing Base and Competitors
    Table 29. Mylan Major Business
    Table 30. Mylan Dermatology OTC Medications Product and Services
    Table 31. Mylan Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Mylan Recent Developments/Updates
    Table 33. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 34. Sun Pharmaceutical Major Business
    Table 35. Sun Pharmaceutical Dermatology OTC Medications Product and Services
    Table 36. Sun Pharmaceutical Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Sun Pharmaceutical Recent Developments/Updates
    Table 38. Aurobindo Basic Information, Manufacturing Base and Competitors
    Table 39. Aurobindo Major Business
    Table 40. Aurobindo Dermatology OTC Medications Product and Services
    Table 41. Aurobindo Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Aurobindo Recent Developments/Updates
    Table 43. Galderma Basic Information, Manufacturing Base and Competitors
    Table 44. Galderma Major Business
    Table 45. Galderma Dermatology OTC Medications Product and Services
    Table 46. Galderma Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Galderma Recent Developments/Updates
    Table 48. CR SANJIU Basic Information, Manufacturing Base and Competitors
    Table 49. CR SANJIU Major Business
    Table 50. CR SANJIU Dermatology OTC Medications Product and Services
    Table 51. CR SANJIU Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. CR SANJIU Recent Developments/Updates
    Table 53. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
    Table 54. Dr. Reddy's Major Business
    Table 55. Dr. Reddy's Dermatology OTC Medications Product and Services
    Table 56. Dr. Reddy's Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Dr. Reddy's Recent Developments/Updates
    Table 58. Lupin Basic Information, Manufacturing Base and Competitors
    Table 59. Lupin Major Business
    Table 60. Lupin Dermatology OTC Medications Product and Services
    Table 61. Lupin Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Lupin Recent Developments/Updates
    Table 63. Bausch Health Basic Information, Manufacturing Base and Competitors
    Table 64. Bausch Health Major Business
    Table 65. Bausch Health Dermatology OTC Medications Product and Services
    Table 66. Bausch Health Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Bausch Health Recent Developments/Updates
    Table 68. Cipla Basic Information, Manufacturing Base and Competitors
    Table 69. Cipla Major Business
    Table 70. Cipla Dermatology OTC Medications Product and Services
    Table 71. Cipla Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Cipla Recent Developments/Updates
    Table 73. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 74. Qilu Pharmaceutical Major Business
    Table 75. Qilu Pharmaceutical Dermatology OTC Medications Product and Services
    Table 76. Qilu Pharmaceutical Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Qilu Pharmaceutical Recent Developments/Updates
    Table 78. Almirall Basic Information, Manufacturing Base and Competitors
    Table 79. Almirall Major Business
    Table 80. Almirall Dermatology OTC Medications Product and Services
    Table 81. Almirall Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Almirall Recent Developments/Updates
    Table 83. Lingrui Basic Information, Manufacturing Base and Competitors
    Table 84. Lingrui Major Business
    Table 85. Lingrui Dermatology OTC Medications Product and Services
    Table 86. Lingrui Dermatology OTC Medications Sales Quantity (M Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Lingrui Recent Developments/Updates
    Table 88. Global Dermatology OTC Medications Sales Quantity by Manufacturer (2018-2023) & (M Units)
    Table 89. Global Dermatology OTC Medications Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 90. Global Dermatology OTC Medications Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 91. Market Position of Manufacturers in Dermatology OTC Medications, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 92. Head Office and Dermatology OTC Medications Production Site of Key Manufacturer
    Table 93. Dermatology OTC Medications Market: Company Product Type Footprint
    Table 94. Dermatology OTC Medications Market: Company Product Application Footprint
    Table 95. Dermatology OTC Medications New Market Entrants and Barriers to Market Entry
    Table 96. Dermatology OTC Medications Mergers, Acquisition, Agreements, and Collaborations
    Table 97. Global Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
    Table 98. Global Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
    Table 99. Global Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
    Table 100. Global Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
    Table 101. Global Dermatology OTC Medications Average Price by Region (2018-2023) & (USD/Unit)
    Table 102. Global Dermatology OTC Medications Average Price by Region (2024-2029) & (USD/Unit)
    Table 103. Global Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 104. Global Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 105. Global Dermatology OTC Medications Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Global Dermatology OTC Medications Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Global Dermatology OTC Medications Average Price by Type (2018-2023) & (USD/Unit)
    Table 108. Global Dermatology OTC Medications Average Price by Type (2024-2029) & (USD/Unit)
    Table 109. Global Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 110. Global Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 111. Global Dermatology OTC Medications Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. Global Dermatology OTC Medications Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. Global Dermatology OTC Medications Average Price by Application (2018-2023) & (USD/Unit)
    Table 114. Global Dermatology OTC Medications Average Price by Application (2024-2029) & (USD/Unit)
    Table 115. North America Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 116. North America Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 117. North America Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 118. North America Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 119. North America Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
    Table 120. North America Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
    Table 121. North America Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. North America Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Europe Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 124. Europe Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 125. Europe Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 126. Europe Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 127. Europe Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
    Table 128. Europe Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
    Table 129. Europe Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 132. Asia-Pacific Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 133. Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 134. Asia-Pacific Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 135. Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
    Table 136. Asia-Pacific Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
    Table 137. Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
    Table 138. Asia-Pacific Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
    Table 139. South America Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 140. South America Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 141. South America Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 142. South America Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 143. South America Dermatology OTC Medications Sales Quantity by Country (2018-2023) & (M Units)
    Table 144. South America Dermatology OTC Medications Sales Quantity by Country (2024-2029) & (M Units)
    Table 145. South America Dermatology OTC Medications Consumption Value by Country (2018-2023) & (USD Million)
    Table 146. South America Dermatology OTC Medications Consumption Value by Country (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2018-2023) & (M Units)
    Table 148. Middle East & Africa Dermatology OTC Medications Sales Quantity by Type (2024-2029) & (M Units)
    Table 149. Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2018-2023) & (M Units)
    Table 150. Middle East & Africa Dermatology OTC Medications Sales Quantity by Application (2024-2029) & (M Units)
    Table 151. Middle East & Africa Dermatology OTC Medications Sales Quantity by Region (2018-2023) & (M Units)
    Table 152. Middle East & Africa Dermatology OTC Medications Sales Quantity by Region (2024-2029) & (M Units)
    Table 153. Middle East & Africa Dermatology OTC Medications Consumption Value by Region (2018-2023) & (USD Million)
    Table 154. Middle East & Africa Dermatology OTC Medications Consumption Value by Region (2024-2029) & (USD Million)
    Table 155. Dermatology OTC Medications Raw Material
    Table 156. Key Manufacturers of Dermatology OTC Medications Raw Materials
    Table 157. Dermatology OTC Medications Typical Distributors
    Table 158. Dermatology OTC Medications Typical Customers
List of Figures
    Figure 1. Dermatology OTC Medications Picture
    Figure 2. Global Dermatology OTC Medications Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Dermatology OTC Medications Consumption Value Market Share by Type in 2022
    Figure 4. External Use Examples
    Figure 5. Oral Examples
    Figure 6. Global Dermatology OTC Medications Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Dermatology OTC Medications Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Examples
    Figure 9. Drug Store Examples
    Figure 10. Other Examples
    Figure 11. Global Dermatology OTC Medications Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Dermatology OTC Medications Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Dermatology OTC Medications Sales Quantity (2018-2029) & (M Units)
    Figure 14. Global Dermatology OTC Medications Average Price (2018-2029) & (USD/Unit)
    Figure 15. Global Dermatology OTC Medications Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Dermatology OTC Medications Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Dermatology OTC Medications by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Dermatology OTC Medications Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Dermatology OTC Medications Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Dermatology OTC Medications Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Dermatology OTC Medications Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Dermatology OTC Medications Average Price by Type (2018-2029) & (USD/Unit)
    Figure 30. Global Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Dermatology OTC Medications Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Dermatology OTC Medications Average Price by Application (2018-2029) & (USD/Unit)
    Figure 33. North America Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Dermatology OTC Medications Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Dermatology OTC Medications Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Dermatology OTC Medications Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Dermatology OTC Medications Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Dermatology OTC Medications Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Dermatology OTC Medications Market Drivers
    Figure 74. Dermatology OTC Medications Market Restraints
    Figure 75. Dermatology OTC Medications Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Dermatology OTC Medications in 2022
    Figure 78. Manufacturing Process Analysis of Dermatology OTC Medications
    Figure 79. Dermatology OTC Medications Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Dermatology OTC Medications Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Dermatology OTC Medications Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 05 Jun 2021

date Pharma & Healthcare

The Dermatology OTC Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Dermatology OTC Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Dermatology OTC Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Global Dermatology OTC Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Dermatology OTC Medications Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dermatology OTC Medications market size was valued at USD 13150 million in 2023 and is forecast to a readjusted size of USD 16350 million by 2030 with a CAGR of 3.2% during review period.

Product Tags

dermatology otc medications

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>